Tag: Optinose

Yardley-based Optinose will enact a 1-for-15 reverse stock split to boost its share price and fend off a potential NASDAQ delisting, writes…

Yardley-based Optinose got the green light from the Food and Drug Administration for their flagship nasal spray Xhance, writes John George for the Philadelphia…

Yardley-based Optinose, known for its drug-device product Xhance, is at a pivotal moment as it awaits a decision from the Food and Drug…

Several businesses in Bucks County were recently listed among the top public companies in the local region. Todd Romero wrote about the companies for the…

As the longtime CEO of a major Bucks County company announces his retirement, his replacement has already been chosen and announced. John George wrote about…

A Bucks County pharmaceutical company is set to raise a large sum of money through recent financial dealings they have partaken in. John George wrote…

Optinose, the Yardley pharmaceutical company, has announced that Chief Financial Officer Keith A. Goldan has accepted a position at another public company. Optinose focuses on…

Late last week, Optinose of Yardley closed its effort to raise $40 million through the sale of company stock. The capital infusion will expand its…